In addition, this nanoparticle also triggered cell surface exposure of CALR, as well as an abscopal effect in tumor-bearing mice, which likely increased the efficacy of ICIs through a more important recruitment of CD4+ and CD8+ cytotoxic T-cell populations in the tumors [97]. The gene discussed is CALR; the disease is neoplasm.